CoChat

Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial

Morishita, Daisuke, Tomita, Toshihiko, Mori, Sumire, Kimura, Takeshi, Oshima, Tadayuki, Fukui, Hirokazu, Miwa, Hiroto · 2021 · American Journal of Gastroenterology

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: This is the first prospective, double-blinded, randomized, placebo-controlled trial to evaluate the safety and efficacy of a stimulant laxative compared with an osmotic agent for the treatment of chronic idiopathic constipation. METHODS: Patients were randomly administered stimulant laxative (senna, 1.0 g), osmotic agent (magnesium oxide [MgO], 1.5 g), or placebo for 28 consecutive days. The primary endpoint was overall symptom improvement. Secondary endpoints were spontaneous bowel movement (SBM), complete SBM, and patient assessment of constipation quality of life (QOL). RESULTS: Ninety patients (mean age, 42 years; 93% women; mean duration of symptoms, 9.9 years) were enrolled; all completed the study. The response rate for overall improvement was 11.7% in the placebo group, 69.2% in the senna group, and 68.3% in the MgO group ( P < 0.0001). Change in SBM was significantly greater in the senna and MgO groups than that in the placebo group ( P < 0.001). Similarly, change in complete SBM was significantly greater in the senna and MgO groups than that in the placebo group ( P < 0.01). On the patient assessment of constipation QOL, significant improvements were seen in the senna and MgO groups compared with those in the placebo group (senna, P < 0.05; MgO, P < 0.001). The frequency of severe treatment-related adverse events was 0%. DISCUSSION: Senna and MgO significantly improved the frequency of bowel movements and QOL score and seem to be effective in the treatment of constipation.

Overview

Integrity signals

Registry

Crossref · 10.14309/ajg.0000000000000942

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. Sakimura, 1998, Clinical evaluation of YO-106 (magnesium oxide tablets) in the treatment of habitual constipation—A cross over study with magnesium oxide powders, Jpn Pharmacol Ther, 26, 1027

Cited by

See all 65

Metadata

Authors
Morishita, D., Tomita, T., Mori, S., Kimura, T., Oshima, T., Fukui, H., & Miwa, H.
Affiliations
Hyogo Medical University (JP)
Corresponding author
Miwa, Hiroto
Venue
American Journal of Gastroenterology
Published
2020-09-22
Volume
116
Issue
1
Pages
152-161
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W3087944579
Cited by
65
References
39
Citations by year
2026: 12 · 2025: 5 · 2024: 13 · 2023: 17 · 2022: 12 · 2021: 5 · 2020: 1
FWCI
7.60
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
  • Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
Keywords
chronic idiopathic constipation, Senna, magnesium oxide, stimulant laxatives, osmotic laxatives, spontaneous bowel movements, constipation quality of life
MeSH terms
Sennosides, Adult, Aged, Chronic Disease, Constipation, Double-Blind Method, Female, Humans, Magnesium Oxide, Male, Middle Aged, Quality of Life, Treatment Outcome, Laxatives, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.14309/ajg.0000000000000942
The paper
Morishita, D., Tomita, T., Mori, S., Kimura, T., Oshima, T., Fukui, H., & Miwa, H. (2021). Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000000942

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.